Introduction Surgical adjuncts in cataract surgery are often perceived as sometimes necessary, always expensive, particularly in the "lean" cost-saving era. However, prevention of a surgical complication, rather than subsequent management, should always be the preferred strategy. We wished to model real-world costs associated with surgical adjuncts use and test the maxim for cataract surgery-"if you think of it, use it". Methods We compared UK list prices for equipment and related costs of preventing vitreous loss (VL) via use of surgical adjuncts vs its subsequent management in a hypothetical cataract surgery scenario of a white swollen cataract with a moderately dilated pupil. Results The original surgery costs for the "cautious with adjuncts, no complications" approach was £943.54, including adjuncts costing £137.47. In the "minimalist, no adjunct" scenario, management of VL using the Anterior Vitrectomy Kit cost £142.45, and additional management and follow-up costs resulted in total cost of £1178.20 (£234.66 (25%) more expensive). If left aphakic, an additional operation for secondary iris clip IOL insertion and further follow-up to address the impact of the complication ultimately cost £2124.67 overall. An additional initial spend on surgical adjuncts of £137.47 could potentially prevent £1293.60 (9× increase) in direct costs in this scenario. Conclusions Through simple scenario modelling, we have demonstrated the cost benefits provided by the use of precautionary surgical adjuncts during cataract surgery. VL costs significantly more in terms of complication management and follow-up. This supports the cataract surgeon's maxim-"if you think of it, use it".
Introduction
Cataract surgery is one of the most successful elective surgical operations undertaken in the NHS. The RCOphth National Ophthalmology Database study of cataract surgery reported that 50.8% of patients achieved postoperative bestcorrected visual acuity of "0.00 logMAR or better", and 94.6% achieved "0.30 logMAR or better" [1, 2] . Cataract surgery has also been demonstrated to be beneficial and cost-effective in patients with a guarded prognosis, including vision-limiting conditions, such as advanced glaucoma or age-related macular degeneration [3, 4] . There is a small, but significant, risk of visually significant complications following cataract surgery-endophthalmitis, retinal detachment and cystoid macular oedema (CMO) [1, 5, 6] . The incidence of these conditions increases in the setting of intra-operative posterior capsular rupture (PCR) and vitreous loss (VL), surgical complications which can lead to endophthalmitis (eight times more likely-odds ratio [OR] = 7.94), retinal detachment (OR = 41.66) and CMO (relative risk [RR] = 2.61) [1, 6, 7] . It follows that optimal management of an intra-operative complication is of paramount importance to the eventual visual outcome. For example, Osher's group reported that 48% of anterior capsule tears extend around the equator through the posterior capsule, and 19% require a vitrectomy [8] .
In light of this, many authors have recommended the use of prior simulation to guide the surgeon in these rare but predictable surgical scenarios, through low-cost surveys of trainee experience, wet and dry laboratory facilities and computer simulation [9] [10] [11] [12] [13] [14] [15] [16] [17] . Ease of access to a pre-prepared Anterior Vitrectomy Kit with associated adjuncts (AntVitKit) to help with the prompt and appropriate management of VL has been previously described [18] .
At the recent UKISCRS annual meeting's Plenary Symposium regarding "How to manage Vitreous Loss" in September 2017, concern was raised during a period of open discussion from a member of the audience regarding the cost of simulating such clinical scenarios on a recurrent basis for both trainees and staff [18] . The panel's response correctly focussed on the greater cost of not carrying out regular simulation training, resulting in sub-optimal management of rare events and the potential for further complications [19] . Prevention of a surgical complication, rather than subsequent management, should always be the preferred strategy. However, we acknowledge the reality that often such strategies have not been clearly quantified. Surgical adjuncts are often perceived to be expensive, particularly in the modern cost-saving era of "lean surgical practices". In light of this, we wished to model a common clinical cataract surgery scenario to illustrate the finances involved and test the following frequently used maxim: when considering surgical adjuncts during cataract surgery training, and beyond-"if you think of it, use it".
All ophthalmic surgeons will have encountered the internal debate at the start of a cataract operation where they have been faced with a sub-optimal pupil or reduced red reflex and found themselves considering the impact, utility or need of using additional surgical adjuncts such as mechanical iris dilation devices, capsular staining with trypan blue dye or intracameral agents [20] . But what bearing should cost have on such a decision, and what is the true cost of the alternative?
Methods
We considered the direct medical costs associated with a specific intra-operative cataract scenario (a white swollen cataract with a moderately dilated pupil) and estimated the cost of using additional surgical adjuncts to avoid a complication (cautious/safe surgery-scenario A). We compared this to the cost and the subsequent impact of experiencing the complication of PCR/VL in the setting of not initially using surgical adjuncts (minimalistic approach -scenarios B and C, see below).
The preferred practice of the senior authors has been used for illustrative purposes and includes the ready-to-use AntVitKit (a prefilled bag containing an anterior vitrector, triamcinolone, acetylcholine and a 10-0 nylon suture) described previously for use in combination with a regular "vitreous loss fire drill" [18] . To avoid issues of commercial sensitivities and potential cost variability between ophthalmology departments, cited costs are the UK product list prices (including 20% VAT), obtained directly from each manufacturer in April 2018 (Pound sterling, £). Unknown costs which are of similar magnitude in both scenarios are mentioned but can be ignored for the purposes of this article, as the primary commentary will focus on the proportional difference in costs.
Scenario A: Complex cataract surgery, additional adjuncts used, but no complications A "cautious" approach to a white swollen cataract and moderately dilated pupil, including the use of an iris expansion ring device, trypan blue capsular staining and denser cohesive viscoelastic, results in complex but uncomplicated surgery. Routine postoperative follow-up was deferred to community optometry.
Scenario B: Complicated cataract surgery, no adjuncts used initially, VL encountered, sulcus lens inserted during primary procedure A "minimalist" approach to a similar cataract scenario, with no preventative surgical adjuncts used, resulted in PCR and VL. No nuclear fragments were lost posteriorly. Following an anterior vitrectomy, there was sufficient capsular support to place a three-piece lens in the sulcus. This patient requires follow-up in the clinic at day 1 and 1 month postoperatively.
Scenario C: Complicated cataract surgery, no adjuncts used initially, VL encountered, no capsule support, left aphakic, iris clip lens inserted as a secondary procedure
The same "minimalist" approach resulted in PCR and VL with no nuclear fragments lost posteriorly. Following an anterior vitrectomy, there was insufficient capsular support and the patient was left aphakic. This patient will be reviewed in the clinic at day 1 and secondary iris clip IOL insertion will be planned. They will require a further surgical procedure and will have to attend at least one additional clinic visit following each procedure. Tables 1 and 2 outline the direct medical costs estimated to arise in each scenario. For simplicity, we assumed that there were no additional associated complications other than what has been modelled in these scenarios.
Results

Original surgery costs
The original surgery costs for the "cautious approach" scenario A was £943.54. This included an additional initial spend of £137.47 on surgical adjuncts.
The cost of managing VL using the Anterior Vitrectomy Kit was £142.45 resulting in the original surgery costs for the "minimalistic approach, no adjuncts, VL, sulcus IOL" scenario B of £908.20 and the original surgery costs for the "minimalistic approach, no adjuncts, VL, left aphakic" scenario C of £843.20.
Follow-up and future management costs
As there was no requirement for further follow-up in scenario A, future management costs with the "cautious but uncomplicated" approach were £0.
The additional costs due to further follow-up and intervention to address the impact of the complication in the "minimalistic approach" were £347.13 if a sulcus lens was implanted during the primary procedure (scenario B) and £1293.60 if an iris clip lens was inserted as a secondary procedure (scenario C). In scenario C, the minimum physical impact for the patient would be a loss of 3 working days due to one further surgical procedure and two additional clinic appointments (as a minimum) and the visual inconvenience/impact of monocular aphakia for the period of time between the two procedures. 
Overall costs
The total overall cost of the "cautious approach" scenario A, with complications avoided, was £943.54. This was 55.6% less than that of the "minimalist approach" scenario C, with which a complication was encountered and an iris clip lens was later inserted (£2124.67), and 19.9% less than that of "minimalist approach" scenario B in which the same Table 2 Table modelling complication was encountered and a sulcus lens was implanted during the primary procedure (£1178.20).
When the above calculations were performed using the prices actually paid by NHS Greater Glasgow & Clyde in April 2018 (i.e. personal communication of local contract prices), rather than the list prices, the total overall cost of scenario A was 24.1% less than for scenario B and 56.7% less than for scenario C.
To summarize, an additional initial spend of £137.47 on surgical adjuncts (scenario A) could potentially prevent £347.13 (2.5 times) or £1293.60 (9.4 times) further direct costs identified with the management of the surgical complication of VL encountered in scenarios B or C, respectively.
Discussion
The current published literature discussing the costs of modern cataract surgery understandably focus on technological advancements [21] . These include the delivery of ultrasound energy (femto vs phaco), type of operation (phaco vs small incision extracapsular cataract extraction) and devices to create a reproducible circular anterior capsulorrhexis (laser vs zepto vs other) [21] [22] [23] [24] . There is a relative paucity of specific information in the literature regarding the cost of a complication. Such publications tend to arise from countries with electronic billing systems, where large data sources can be trawled for trends.
Schmier et al. used United States Medicare Limited Data Sets to identify patients who had developed a specific complication (postoperative CMO; postoperative endophthalmitis) following cataract surgery and those who did not ("controls") [25] [26] [27] [28] . By considering the total reimbursements paid, they identified the increased cost of managing these complicated cases in both instances. In the case of CMO, this was an 85% increase vs "control" ($2720 vs $1470), and in the case of endophthalmitis, a 78% increase ($11,551 vs $6488) [27, 28] . In these examples, the additional increased cost of complication-related CMO and endophthalmitis have been estimated in the USA system to be in the region of $1250 and $5000, respectively. This real-world analysis cannot, however, provide more specific details regarding which, if any, precautionary measures were adopted in each case.
Through our worked example, we have highlighted the potential financial benefits provided by the appropriate use of surgical adjuncts during cataract surgery. There are some clear principles to be gleaned from identifying the true costs of surgical behaviour. The first misconception is a commonly held belief that using surgical adjuncts are expensive, an unhelpful statement when made without context. In the setting of complex surgery, it is more cost-effective to prevent a complication, rather than having to manage it. We have shown that the initial additional spend of £137.47 on appropriate surgical adjuncts has, in the "cautious" scenario A, prevented £347.13 and £1293.60 in further costs identified with the management of the surgical complication of VL encountered in scenarios B and C, respectively. Moreover, once the surgeon has had to open the Anterior Vitrectomy Kit at a cost of £142.45, any initial cost saving from not using surgical adjuncts has evaporated. This reinforces the importance of forward planning prior to surgery.
The second principle to note is that surgical complications are ultimately much more expensive, both in the initial and future management. These costs are not always clearly stated nor are they always acknowledged, as they often come from different budgets (theatre costs administrated separately from outpatient follow-up). Hence, we have tried to demonstrate the true costs associated with safe surgery vs complicated surgery. We have outlined just two "complicated scenarios", but the costs incurred would be greatly increased if, for example, the hypothetical patient suffered a dropped nucleus, requiring vitreo-retinal input, or had further significant postoperative complications, such as CMO, retinal detachment or endophthalmitis.
In this paper, we have not itemized the carbon footprint associated with each of our three scenarios, but it could be expected to be significantly greater in the case of a surgical complication. The carbon footprint of cataract surgery is currently a topic of much debate, and while it can be correctly used as a driver to reduce unnecessary waste, it can inadvertently result in a lack of effective (often disposable) equipment being available for the surgeon [29] [30] [31] [32] . Any drive to "lean" working practices should not result in such lowstock equipment levels that the patient's surgical management, and subsequent outcomes, could be jeopardized and have medico-legal implications. This may be of increasing relevance, as a recent 15-year report on 963 clinical negligent cases in ophthalmology reported the cataract subspecialty as having the highest number of claims (34%) [33] .
Our comparison also does not consider the financial impact of potentially long-term visual impairment, as described by Frick et al. (including increased expenditure on other medical care, non-medical expenditures such as aids and adaptations, increased travel costs and loss of productivity, both for the patient and potentially their relatives) [34] [35] [36] . It also cannot consider, finances aside, the amount of anxiety experienced by the patient, the potential impact on their quality of life or the effect that potential visual impairment could have on the patient's family, caregivers and the community. In this instance, Getting It (the surgery) Right First Time has a huge impact on both patient and the hospital. "Getting It Right First Time" (GIRFT) is a recent orthopaedic-based report that addressed unnecessary variations in pathways of care, patient experiences and surgical outcomes. These concepts are currently being applied to other sub-specialties (including ophthalmology) [37] . We acknowledge that our basic modelling is limited, as sometimes the minimalist approach will be uneventful, and on other occasions using surgical adjuncts will not prevent complications, but their appropriate utilization should reduce the frequency of VL (in conjunction with risk stratification and appropriate case selection) [5] . In line with the GIRFT principles, it is our belief that the availability and use of surgical adjuncts may be a clear instance where "spending a little can save a lot more" in future costs.
Conclusion
Through basic modelling of potential outcomes from the surgical approach to a white cataract with moderate pupil dilation, we have demonstrated the real-world cost benefits associated with the use of precautionary surgical adjuncts in prevention vs management of the common complication of PCR/VL in cataract surgery. Without published data reporting the RR reduction in the incidence of PCR offered by use of individual surgical adjuncts, it is not possible to perform a specific cost-effectiveness analysis. Despite this, we believe that this article has addressed and quantified some of the issues influencing surgical decision making and additional equipment use. VL costs significantly more in terms of complication management and follow-up, both to the ophthalmology department and, much more importantly, the patient. We have also provided an evidence base to support the maxim for the operating surgeon with regards to surgical adjuncts-"if you think of it, use it".
Summary
What was known before
• Surgical adjuncts in cataract surgery are often perceived as sometimes necessary, but always expensive, particularly in the lean cost-saving era.
• Prevention of a surgical complication, rather than subsequent management, should always be the preferred strategy.
• Trainee surgeons are often taught the maxim regarding surgical adjuncts in cataract surgery-if you think of it, use it.
What this study adds
• An additional initial spend on surgical adjuncts of £137.47 could potentially prevent £1293.60 (9×) in direct costs from management of vitreous loss.
• The cost of using the Anterior Vitrectomy Kit was £142.45, so negating any potential saving from not initially using surgical adjuncts.
• This article has quantified some of the costs influencing surgical decision making and additional equipment use, demonstrating that it is cheaper to prevent, rather than manage, a complication.
• We have provided an evidence base to support the maxim for the operating surgeon with regards to surgical adjuncts-if you think of it, use it.
